Live Breaking News & Updates on Ram Mukunda

Stay updated with breaking news from Ram mukunda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1

Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer s

. ....

United States , Port Charlotte , Ram Mukunda , Liliana Montoya , George Li , Neurostudies Inc , Pharma Inc , Exchange Commission , Principal Investigator , Risk Factors , Annual Report ,

IGC Pharma Adds Advisor in Artificial Intelligence

IGC Pharma, Inc. today announces the addition of Pablo Arbelaez, Ph.D., an expert in artificial intelligence and one of the world s top researchers. Dr. Arbelaez will support the development of. ....

United States , France General , Pablo Arbelaez , Los Andes , Ram Mukunda , Pablo Arbel , Dauphine University , University Of California , Computer Vision Group , Pharma Inc , Alzheimer Association , Exchange Commission , Computer Vision , Universidad De Los Andes , Applied Mathematics , Paris Dauphine University , Biomedical Engineering , Universidad De Los , Artificial Intelligence , Latin America , Latin American , Looking Statements , Risk Factors , Annual Report , Quarterly Report ,

IGC Pharma : Announces Positive Interim Results for IGC-AD1 in - Form 8-K -April 05, 2024 at 11:36 am EDT

IGC Pharma Announces Positive Interim Results for IGC-AD1 in

Reducing Alzheimer s Agitation

- Interim Data: Study Achieves Primary End Point Demonstrating. ....

United States , Ram Mukunda , Janet Vasquez , Rosalyn Christian , Pharma Inc , Drug Administration , Exchange Commission , Announces Positive Interim Results , Statistically Significant Reductions Compared , Agitation Associated , Dementia Due , Cohen Mansfield Agitation Inventory , Specified Interim Results , Illustrative Brexpiprazole Phase , Artificial Intelligence , Looking Statements , Risk Factors , Annual Report , Quarterly Report ,

IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer's Pipeline -March 12, 2024 at 03:01 pm EDT

IGC Pharma, Inc. today announced that it has appointed Terry Lierman as an independent director to its board of directors.

Mr. Lierman is currently Co-Chair of the Board of Advisors at the. ....

White House , District Of Columbia , United States , Terry Lierman , Ram Mukunda , Committee On Appropriations , Children Research Institute , Pancreatic Cancer Action Network Pan , Follette School Of Public Affairs , University Of Wisconsin , Pharma Inc , National Cancer Institute , Exchange Commission , National Institutes Of Health , Institute Of Human Virology , National Organization On Fetal Alcohol Syndrome , Us Senate , Human Virology , Public Affairs , Research Institute , Pancreatic Cancer Action Network , National Organization , Fetal Alcohol Syndrome , National Institutes , Staff Director , Artificial Intelligence ,

IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer's Pipeline

IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer's Pipeline
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

White House , District Of Columbia , United States , Rosalyn Christian , Terry Lierman , Ram Mukunda , Janet Vasquez , National Institutes Of Health , National Cancer Institute , Exchange Commission , University Of Wisconsin , Pharma Inc , Children Research Institute , Committee On Appropriations , Pancreatic Cancer Action Network Pan , Follette School Of Public Affairs , Us Senate , National Organization On Fetal Alcohol Syndrome , Institute Of Human Virology , Human Virology , Public Affairs , Research Institute , Pancreatic Cancer Action Network , National Organization , Fetal Alcohol Syndrome , National Institutes ,